OTC · Financial Statements
DNA Brands, Inc. (DNAX) Financial Statements
$0.00
OTC: DNAX
Market Cap $171816
Overview Financials Dividend
DNA Brands, Inc. most recently reported annual revenue of $0, net profit of $-1.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2020 2021 2022 2023 2024
Revenue $0 $0 $0 $0 $0 Operating Profit $-1.0M $0 $0 $0 $0 Net Profit $-1.0M $0 $0 $-1.0M $-1.0M EPS $-0.24 $0.00 $0.00 $0.00 $0.00 Op Margin -499.6% -66.2% — — —
Balance Sheet (USD)
Metric 2020 2021 2022 2023 2024
Total Assets $1.0M $1.0M $0 $0 $0 Total Liabilities $3.0M $3.0M $3.0M $4.0M $5.0M Cash $0 $0 $0 $0 $0 Borrowings $2.0M $2.0M $2.0M $3.0M $3.0M
Cash Flow (USD)
Metric 2020 2021 2022 2023 2024
Operating Cash Flow $-1.0M $0 $0 — $0 Investing Cash Flow $1.0M $0 $0 — $0 Financing Cash Flow $0 $0 $0 — $0 Net Cash Flow $0 $0 $0 — $0 Free Cash Flow $-1.0M $0 $0 $0 $0
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA -20.99 FCF Yield 0.00% Quick Ratio 0.01 Interest Coverage -1.34 Return 1Y 0.00% Return 3Y -91.67% Return 5Y —
Screens featuring this stock